Informing the Future Critical Issues in Health, Sixth Edition (2011) / Chapter Skim
Currently Skimming:
The Value of Collaboration: IOM's Role as a Convener
The Value of Collaboration: IOM's Role as a Convener
Pages 139-148
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 139... ...
Through both its ongoing roundtables, sometimes called forums, and through unique partnerships, the IOM shapes the conversation around health and health care. Partnerships with outside organizations bring complementary strengths and enable the IOM to amplify the size and character of its audience and the impact of its work.
|
From page 140... ...
This year the IOM and HHS enlarged the program, with a second meeting held in June 2011. The forum, held at the Natcher Conference Center at the NIH, was attended by more than 550 participants from information technology firms, healthcare delivery systems, academia, business, social sectors, public health communities, and all levels of gov Kathleen Sebelius, Secretary of the Department of Health and Human Services, addresses the Health Data Initiative Forum, June 9, 2011.
|
From page 141... ...
Although creating common ground can occur through formal committees with specific objectives and areas of study, it often takes place through forums, roundtables, and symposia that provide opportunities for serendipitous discovery, mutual exchange, and critical, cross-disciplinary thinking. The IOM holds symposia, sometimes called summits or workshops, to foster awareness or focus attention on important issues, or to help broaden awareness about a recently released IOM report.
|
From page 142... ...
The forum brings ongoing attention and visibility to important issues in drug development; explores new approaches for resolving problem areas; helps define the scope of the field and thus sets the stage for future policy action; provides a catalyst for collaboration on top ics where there is synergy among potential partners; and elevates the general understanding of drug dis covery, development, and translation among the research, public policy, and broader communities. The forum recently has considered a vast array of issues, ranging from drug regulation and regulatory decision making to medical countermeasures during public health emergencies.
|
From page 143... ...
Most recently, the forum held workshops that considered the 2009 H1N1 pandemic vaccination campaign, examined medical and public health preparedness and response in rural and frontier settings, and, in a workshop cosponsored with the Forum on Drug Discovery, Development, and Translation, discussed methods to improve how medical countermeasures are developed, tested, and approved.
|
From page 144... ...
In recent years, forum dialogues have illuminated priorities in infectious disease research and public health policy; the use of new scientific and policy tools; and opportunities for more effective collaboration between the private and the public sectors. Recent workshops have focused on the science and policy implications of neglected tropical diseases, the recent emergence of multidrug-resistant "superbugs," and the threat of fungal diseases.
|
From page 145... ...
The forum considers a range of issues in science, clinical medicine, public health, and public policy relevant to the goals of preventing, palliating, and curing cancer. Its objectives are to identify emerging high-priority policy issues in the nation's effort to combat cancer and to examine those issues through convening activities that promote discussion about potential opportunities for action.
|
From page 146... ...
Roundtable on the Promotion of Health Equity and the Elimination of Health Disparities The Roundtable on the Promotion of Health Equity and the Elimination of Health Disparities focuses on issues related to the visibility of racial and ethnic disparities in health and health care as a national problem, the development of programs and strategies to reduce disparities, and the need to encourage new leadership in a variety of fields. Roundtable members include experts from the health and social sciences, industry, and the community.
|
From page 147... ...
The roundtable fosters dialogue across sectors and institutions and fosters collaboration among stakeholders. Roundtable on Value & Science-Driven Health Care The Roundtable on Value & Science-Driven Health Care, established in 2006 as the Roundtable on Evidence-Based Medicine, provides a trusted venue for national leaders in health care to work cooperatively toward their common commitment to effective, innovative health care that consistently adds value to patients and society.
|
From page 148... ...
incentives for value in health care.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.